Abstract
The differences between racial/ethnic groups in cancer incidence and survival are greater for cancer of the uterine corpus than for any other major cancer site. According to 1978–1981 data from the Surveillance, Epidemiology, and End Results (SEER) Program (Baquet et al. 1986), the incidence of corpus cancer ranged from 2.6 per 100,000 Native Americans to 27.1 per 100,000 Native Hawaiians with a White:Black ratio of 1.9 (Table 1). The five-year survival ranged from a high of 88% in Whites to 57% in Blacks, a difference of 31%. For breast cancer, in comparison, the White:Black incidence ratio was only 1.2 and the difference in five-year survival was only 12%. Since corpus cancer is the fourth most frequent cancer in U.S. women, with 35,000 new cases estimated for 1987, its diagnosis and treatment involves much expensive medical care, and its prevention is clearly of great significance. The existence of differences between populations often suggests that some aspects of a disease are indeed preventable and thus justifies a detailed analysis of ethnic differences in all factors that contribute to the incidence and mortality of corpus cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Cancer Society: Cancer Facts and Figures —1987, p 17. New York: American Cancer Society, 1987.
Antunes CMF, Stolley PD, Rosenshein NB, et al: Endometrial cancer and estrogen use: Report of a large case-control study. N Engl J Med 1979; 300:9–13.
Austin DF, Roe KM: Increase in cancer of the corpus uteri in the San Francisco-Oakland Standard Metropolitan Statistical Area, 1965–75. JNCI 1979; 62:13–16.
Baquet CR, Ringen K, Pollack ES, et al: Cancer Among Blacks and Other Minorities: Statistical Profiles. National Cancer Institute. Bethesda, MD: NIH Publication No 86–2785, 1986.
Centers for Disease Control Cancer and Steroid Ho0072mone Study: Oral contraceptive use and the risk of endometrial cancer. JAMA 1983; 249:1600–1604.
Collins J, Donner A, Allen LH, Adams O: Oestrogen use and survival in endometrial cancer. Lancet 1980; 2:961–964.
De Waard F. Uterine corpus. In Schottenfeld D, Fraumeni JF (eds): Cancer Epidemiology and Prevention, 2nd ed, Philadelphia: Saunders, 1982, pp 901–908.
Easterday CL, Grimes DA, Riggs JA: Hysterectomy in the United States. Obstet Gynecol 1983; 62:203–212.
Elwood JM, Boyes DA: Clinical and pathological features and survival of endometrial cancer patients in relation to prior use of estrogens. Gynecol Oncol 1980; 10:173–187.
Elwood JM, Cole P, Rothman K, Kaplan SD: Epidemiology of endometrial cancer. JNCI 1977;59:1055–1060.
Fruchter RG, Boyce JG: Delays in diagnosis and stage of disease in gynecologic cancer.Cancer Detect Prev 1981; 4:481–486.
Gambrell RD, Bagnell CA, Greenblatt RB: Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: Review. Am J Obstet Gynecol 1983; 146:696–707.
Gray LA, Christopherson WM, Hoover RN: Estrogens and endometrial carcinoma. Obstet Gynecol 1977; 49:385–389.
Haenszel W, Hillhouse M: Uterine-cancer morbidity in New York City and its relation to the pattern of regional variation within the United States. JNCI 1959; 22:1157–1181.
Harlow BL, Weiss NS, Lofton S: The epidemiology of sarcomas of the uterus. JNCI 1986; 76:399–402.
Horm JW, Asire AJ, Young AJ, et al: Cancer Incidence and Mortality in the United States, SEER, 1973–81. US Department of Health and Human Services. Bethesda, MD: NIH Publication No 85–1837, 1985.
Howe HL: Age-specific hysterectomy and oophorectomy prevalence rates and the risks for cancer of the reproductive system. Am J Public Health 1984; 74:560–563.
Hulka BS, Fowler WC, Kaufman DG, et al: Estrogen and endometrial cancer: Cases and two control groups from North Carolina. Am J Obstet Gynecol 1980; 137:92–101.
Kelsey J: Epidemiology of osteoporosis. In Gold EB (ed): The Changing Risk of Disease in Women. Lexington, MA: Collamore Press, 1984, pp 287–298.
Kennedy D, Baum C, Forbes MB: Noncontraceptive estrogens and progestins: Use patterns over time. Obstet Gynecol 1985; 65:441–446.
Koss LG, Schreiber K, Oberlander SG, et al: Detection of endometrial carcinoma and hyperplasia in asymptomatic women. Obstet Gynecol 1984; 64:1–11.
Mack TM, Pike MC, Henderson BE, et al: Estrogens and endometrial cancer in a retirement community. N Engl J Med 1976; 294:1262–1267.
McDonald TW, Annegers JF, O’Fallon WM, et al: Exogenous estrogen and endometrial carcinoma: Case-control and incidence study. Am J Obstet Gynecol 1977; 127:572–580.
McTiernan A, Chu J, Thomas DB: Cancer incidence in Caucasians living in the Pacific Basin. NCI Monogr 1985; 69:65–72.
National Center for Health Statistics: Height and Weight of Adults Ages 18–74 Years by Socioeconomic and Geographic Variables: United States 1971–74. US Vital and Health Statistics Series 11, No 224. Washington DC: US Government Printing Office, 1985.
Petterson F. Annual Report on the Results of Treatment in Gynecological Cancer, Vol 19. Stockholm, Sweden: Radiumhemmet, 1985, pp 123–136.
Polednak AP: Incidence of soft-tissue cancers in Blacks and Whites in New York State. Int J Cancer 1986; 38:21–26.
Russell-Briefel R, Ezzati T, Perlman J: Prevalence and trends in oral contraceptive use in premenopausal females aged 12–54 years, United States, 1971–80. Am J Public Health 1985;75:1173–1176.
Silverberg SG, Makowski EL, Roche WD: Endometrial carcinoma in women under 40 years of age. Cancer 1977; 39:592–598.
Smith DC, Prentice R, Thompson DJ, et al: Association of exogenous estrogen and endometrial cancer. N Engl J Med 1975; 293:1164–1167.
Steinhorn SC, Meyers MH, Hankey BF, Pelham VF: Factors associated with survival differences between Black and White women with cancer of the uterine corpus. Am J Epidemiol 1986; 124:85–93.
Waterhouse J, Muir C, Shanmugaratnam K, et al: Cancer Incidence in Five Continents. IARC Scientific Publications No 42. Lyon, France: International Agency for Researchagainst Cancer, 1982.
Ziel HK, Finkle WD: Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 1975; 293:1167–1170.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Boyce, J.G., Fruchter, R.G. (1989). Cancer of the Corpus Uteri in Black Women. In: Jones, L.A. (eds) Minorities and Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3630-6_15
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3630-6_15
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-8185-6
Online ISBN: 978-1-4612-3630-6
eBook Packages: Springer Book Archive